THE EDITORIAL

Address,

CONTENTS
With advancing times, significant changes and attitudinal shift have been
observed in both women’s and society’s thought about women’s equality
and emancipation. Women today have been successfully winning all •Cover story
battles and climbing the ladder of success in diversified sectors each day.
--Calculative Contraception
Saluting and celebrating the spirit of woman-hood, it gives us immense
pleasure to bring to you the March edition of “THE PUMBA GAZETTE” •Articles/Analysis
dedicated to the woman of today : ‘T he tender, gentle and a flawless
leader.’
--The Pink Shift
In line with this, we bring to you an exclusive interview with Mrs. Roopali
Tople (Criterium Inc., Pune) on clinical trials in India. •Back to Society

In view of the advancements in Intra Uterine Contraceptive Devices --OKHAI Initiative by TATA Chemicals.
(IUCD), our students have undertaken a project with the aim to survey the
awareness and usage pattern of IUCD in Pune city. •BT News
It also includes a section on changing trends in advertisements focusing
on women.
--In support of trials – Truly Asia

We also bring to you one of the 12 part series on various noteworthy CSR •Candid Talk
initiatives. The article titled ‘Back to Society’, covers the initiative by TATA
Chemicals for empowerment of women. --An Interview with Mrs. Roopali Tople

To be abreast with the developments in the industry we have also •PUMBA News
included a section on BT News, and The PUMBA Gazette’s view point on
the same.
--International Conference on Global meltdown
A section based on PUMBA and the happenings in and around the same
has also been included. --PUMBA at BIOASIA Conference 2009

Your Feedback & Suggestions are welcome at

thepumbagazette@gmail.com

“Reading is to the mind what exercise is to the body”

- Joseph Addison

Sincerely Yours,

Chief Editior: Vijendra S. Agarwal, MBA-BT (Sem II)

(THE PUMBA GAZETTE Team)

(The detailed project reports shall be provided on enquiry. Kindly send in

your enquiries at thepumbagazette@gmail.com )

“I am very happy to note that ‘The PUMBA GAZETTE’

Team is dedicating this issue to women.
Women, in general, have to face challenges both at
personal and professional levels to prove their mettle.
It is observed that women are sincere and honest to
their responsibility and fulfil the job expectations.
In fact, today women work at par with men and have
proved to be equal or sometimes even better than the
male force.
Dr.(Capt.) C. M. Chitale, My best wishes to all working women for their future
DEAN , endeavours.”
University Of Pune
Calculative Contraception
Graph 1: Sources of awareness about IUCDs
Surve y about awareness and usage pattern of Intra Uterine 191
Contraceptive Device (IUCD) in Pune city 200
180

Number of women
160

respondents
In view of the International Women’s Day, a survey was 140
120 76
conducted with the aim to study the awareness and usage of 100
80
IUCDs in Pune city. The target sample included 315 married 60 19
women in the age group of 18 to 60 from various strata of society. 40
20
Pune city was divided into six different zones & random sampling 0
Doctors Media Friends &
procedure was used. 35 Gynaecologists from eminent hospitals in Relatives
Pune were also interviewed. The survey revealed that most of the Sources
women in Pune are aware of IUCDs but fall back on account of its
usage. Graph 2: Usage of various contraceptive
measures among women
17.31% 19.23%
IUCDs used in India are found to be of three basic types, Copper
T (CuT), Multi load and hormone releasing devices. However Contraceptive Pills
there are variations of CuT like CuT 380A, CuT 200 etc. The Condoms
survey was aimed at finding out the devices which are usually 13.46% IUCDs
recommended by Gynaecologists and preferred by women. Its Surgical Procedure

objective also included finding out the preferences of IUCDs over No usage

other measures of contraception like contraceptive pills, condoms 26.92%

(used by partner), surgical procedures & spermicidal creams.

23.08%
It was found that about 91% women were aware of IUCDs and
their functions. The various sources of this awareness were Graph 3: Recommendations for IUCDs by
doctors, friends, relatives and media with the major source being doctors
doctors (Graph 1).
CuT
Contraceptive pills were found to be more popular with women of
38%
age group 18-27 years and surgical procedures were preferred in Hormone
Releasing
the age group of 38-47 years (Graph 4). However, both IUCDs 48% CuT 380A
and contraceptives are popular in age group 28-37 years, IUCDs
Multiload
ranking higher than contraceptive pills (Graph 2).

Among IUCD’s, Multiload was found to be negligibly used by

3%
women, the reason being its higher price in comparison to freely
11%
available Copper T in government hospitals. However, it is highly
recommended by doctors (Graph 3). Graph 4: Age group wise preferences for various
contraceptives

The various contraceptive measures like contraceptive pills, 100%

condoms, IUCDs & surgical procedure are advised by doctors. 80%

Preference

The actual usage pattern among women was found to be as 60%

depicted in Graph 2. Women prefer condoms over IUCDs and 40%

contraceptive pills. 20%

0%
IUCD
Contraceptive
Condoms

procedures

48 & above
The majority of doctors interviewed in the survey carried out 5-10
Surgical

38-47
pills

IUCD procedures per month. Among the 35 doctors surveyed, 28-37

50% agreed that some complications occur after installation and
the rest said otherwise.
Few companies in India manufacture IUCDs (that too, only
CopperT). Easy and affordable availability of Multiload will
popularize its usage, since doctors recommend it over CopperT
due to many aspects.
CONCLUSIONS AND SUGGESTIONS
18-27
3. The government should take more efforts to encourage usage
of IUCDs as doctors feel they are safer, convenient and more
reliable than the frequent medical termination of pregnancy and
the use of emergency contraceptive pills.
4. The media (print media, electronic media, internet, radio, etc.)
can be used to create awareness about the usage of IUCDs.

1. Though a large percentage of women surveyed were aware of 5. More Indian manufacturers can enter the IUCD market, so that
the IUCDs, few preferred using them. this potentially untapped market can be explored.

2. Women are reluctant to use IUCDs because of the doubts,

apprehensions, lack of awareness and proper guidelines
regarding its use. Compiled by: Anagha Bhavale, Dipti Tayade , Dr. Nishith Tyagi ,
Snigdha Sinha, Vandita Javali, Vishakha Shinde,
MBA-BT (Sem II)
The Pink Shift
Women are now seen as prospective buyers for previously
It’s said ‘Men are from Mars and Women are from Venus’ and in
tagged ‘masculine’ products. Today companies have an
the advertising world the Martians were the ones thought to be opportunity to tap the women consumer markets. For example,
holding the purse strings with a majority of ads targeted towards Venky's Rock, the wine division of Venkateshwara Hatcheries
them. It was assumed that men took all major financial decisions. (VH) group, wants to become a niche player in the Indian wine
Women in ads were portrayed as being dependent on men, not market. The company plans to launch four brands of wine
making important decisions and as homemakers rather than targeting women consumers.
outside the home. In general, women were often found in ads for A trend towards polarizing is seen in the media now-a-days. One
home products, baby items, cosmetics, and food items whereas of the best examples is seen in the banking and insurance sector.
men were seen in ads for products such as automobiles, alcohol, The ads till the late 90s generally showed a worried father taking
insurance, financial services, and electronic products. Till the end loan for daughter’s marriage. (The motto then being money for
th
of the 20 century a women reminding her husband to take an ‘Beti ki shaddi’).
insurance policy for ‘himself’ so as to secure the entire family and
an advertisement for a bank showing a father taking loan for his On the other hand, an HDFC ad in 2008 shows a daughter gifting
daughter’s marriage, were not uncommon! a cheque to her father for buying a new car and the father saying
“Beti badi ho gayi hai!”
However, women's role in society has been changing. For
example, ads for washing powder were earlier men centric where
the woman was supposed to buy the right powder in order to
st
clean her husband’s collar. But the 21 century career oriented
woman is depicted in ads which portray a policewoman buying
the right detergent so as keep her ‘VARDI’ clean, definitely a 21st
century woman!!

The ad of Priety Zinta shows a successful established woman

who declines a marriage proposal on the basis that “the boy does
not own a landline.” This clearly reflects the changing position of
women in the society and in the advertisers’ minds.

So it is for sure that advertisers have established women as

strong & independent buyers and family decision influencers!
Ads for beauty products, especially fairness cream, have always
been targeted towards women. However women were portrayed
So much so that ads have to scream “Men are back!” Sorry boys
in these ads as male dependent where the entire purpose of
being fair was to secure a suitable husband. However, recently the Venusians have taken over!!!
the ads have been showing career oriented women who wish to
get fair and beautiful in order to pursue a career of their choice.

Women today are also seen as major financial decision makers
by advertisement companies. Women have become significant
buyers of several products like automobiles, insurance, financial
services & electronic devices. In fact, these products are specially
designed and marketed for women.
‘They are slim. They are pink. They have got the curves’. This is
the promo of HP’s latest notebooks, seeking to become the
modern woman’s next fashion accessory.
References:
1. Men and Women in Indian Magazine
Advertisements: A Preliminary Report: Mallika Das
2. L J Busy and G Leichty, Feminism and advertising in traditional
and non-traditional women's magazines 1950s-1980s, Journalism
Quarterly, 70(2), 1993.

Compiled by: Ankita Barve, Dhruva Deshpande,

MBA-BT (Sem II)

Evidences also exist that women are now being portrayed in less
stereotypical ways in ads. A peppy Priyanka Chopra announced
“Why should boys have all the fun!!” Indian advertisers have
taken this seriously knowing that now ‘men moisturize and
women use power tools.’
Back to Society: OKHAI Initiative By
TATA Chemicals

“You are not truly independent until and unless you
are financially independent”.
"Financial security" or “Financial Independence” is
considered to be the top most priority for empowerment of
Indian rural women. Most of the women in rural areas are
financially dependent on their partners. There is a need for
women empowerment at the grass root level which will
help them to take the financial responsibility of herself and
her children.
Tata Chemicals Ltd. (TCL) has truly realized the need for
women empowerment at rural level and has been
facilitating them with various initiatives for the development
of self, family and society. TCL has, with the help of Sir
Dorab Tata Trust, Okhamandal Sewa Trust, Tata-Chem
Golden Jubilee Foundation, and Tata Chemicals Society
for Rural Development (TCSRD), made a marked
improvement over the years in its efforts to make the
people of Okhamandal, a taluka in Saurashtra region, self
reliant in every way.
One such initiative to empower the women of this region is
‘OKHAI’. For this initiative, Okhai trust was registered
under the name ‘Okhai center for Empowerment.’ The
objectives of this trust are--
• To provide employment to local women.
Presently 450 women are working in Okhai out of which
250 are permanent, and 200 are temporary. Okhai
presently covers 13 villages (Arambada society,
Udyognagar, Bhimrana, Okha, Poshitra, Mulvel, Padli,
Rajbra, Dwarka, Bardia, Makanpur, Vernala and Batia)
which consist of 36 Mandals. The women here are also
trained by institutes like NIFT & AVPT Government
College, Ahmedabad.
Okhai has won many consignments like ‘SASHA
Handicraft’, Tajkhajana in the Goa resort, ‘Option shop’,
Rajkot ‘Neemranaz’ (Delhi) and Home Expression
(Bangalore). It conducts exhibitions at various branches of
TCL, Tech Mahindra, TATA Chemicals, TATA Power,
TATA teleservices, TATA-SKY, Oracles & Reliance
(Jamnagar).
Okhai has come a long way in the last year. The first outlet
of Okhai has been inaugurated in the ‘Himalaya’ mall,
Ahmedabad. This initiative has made a great impact on the
social life of women. It has developed a sense of
ownership and belongingness in them. They are
empowered & feel confident about their work at Okhai.
They are now recognized through the exhibitions
conducted to display their finest of the works. This initiative
is another feather in the cap of the company.

• To focus on overall development of women.

In this initiative handicraft skills of women are nurtured and

promoted. The women work on embroidery, pattern
designing, patch work and stitching. The product portfolio
offered by them include apparels (kurta, kurti), home
furnishings (bed sheet, cushion and pillow covers, coffee
and simple table clothes, wall piece, curtains) and
accessories (mobile covers, picnic bags, sling and potli
purses, zola bags, tea coasters)

The programme has a highly organized channel for

distribution of raw material and collection of finished goods.
Based on urgency of the work, amount of the work and
skills demanded, Mandals or Self Help Groups are formed
within the villages. Each group has its own ‘Pramukh’
(head) and ‘Co-Pramukh’ (co-head) who handles activities
of bank, work distribution, primary quality check and all
records.

Every group has its account in the bank in the name of

their head or their group. Records of each woman and their Compiled by: Ameya Budukh, Birendra Choubey, Nivedita Singh
bill book are maintained by this group. TCSRD had allotted Shweta Sharma, MBA-BT (Sem II)
a fund of Rs. 8.5 lakhs for the year 2007-2008.
Special Thanks to: Mr. Omkar Rokade (TATA Chemicals Ltd.)
In Support of Trials - Truly Asia
Malaysia, till recently a tourist destination, has now a lot more
to boast about. It is all set to become a new clinical trial hub,
facilitated by the Malaysian government’s keenness to build a
knowledge infrastructure through scientific collaboration and
promotion of research.The country has time and again lived
up to its reputation in delivering results, owing to its low cost
advantage & its modern medical infrastructure with efficient
logistics for trial supplies and biological samples. The country
also possesses a large and diverse multi-ethnic population,
along with Good Clinical Practice (GCP) certified and English-
literate medical professionals in various therapeutic areas.
Some of the government’s strategies include marketing
Malaysia as a preferable clinical trial destination,
strengthening governance and ethical oversight & the required
human capital. It also focuses on developing research
supporting infrastructure, facilitating access to Malaysian
investigators, strengthening collaboration and partnerships as
well as establishing a sound legal framework. This is backed
by the Clinical Research Centre (CRC), an arm of the Ministry
of Health (MoH).
The MoH is working closely with the Association of Clinical
Research Professionals (ACRP) in human capacity building to
overcome the shortage of highly trained clinical research
professionals. Furthermore, the government sets up fast
timelines for ethical review and regulatory approval and
ensures strict adherence to international regulatory regime
such as compliance with GCP guidelines and Intellectual
Property Rights (IPR) protection. Malaysia's most notable
feature is its comprehensive integrated network of government
healthcare facilities and partner private hospitals, which is
achieved through the CRC. It also aims at improving the
quality and ethical clinical research through a comprehensive
range of services which include phase II to IV clinical trials,
disease management, clinical databases & patient registries
and medical research registration. With its growing network of
centers nationwide, CRC acts as a one-stop-centre that
provides a single point of contact to access all Ministry of
Health (MoH) hospitals and clinics. Moreover, it is actively
seeking Memorandum of Understandings (MoUs) with several
private hospitals and academic institutions to set up similar
centers.
Also the information regarding the ongoing clinical trials can
be obtained from National Medical Research Register
(NMRR), which is a web-based integrated system simplifying
research application. Through this, one can easily track and
obtain information about the number of clinical trials that are
conducted in Malaysian government hospitals. This also
enables transparency and provides information for the public
& researchers and facilitates the research review process.
On the other hand, looking at the Indian scenario, in the past
few years India has become one of the top locations for
outsourced clinical trials, largely because of the reduced cost
of conducting trials. But the attraction of India goes beyond
simple cost considerations because India is more of a
federation of distinct ethnic groups than a homogenous nation.
Also it is becoming more difficult to conduct trials in the West,
as people are becoming more risk averse and less willing to
trust experimental treatments. Secondly, it is the cost factor
that counts. Trials can be conducted in India at a fraction ofthe
price of that of in the US. Trials for standard drugs in the US
cost more than $150m, a figure that can be reduced by
around 60 percent by shipping them to the sub–Continent.
Added features also include faster patient recruitment & the
amendment of schedule Y of the Drugs & Cosmetics Act in
the year 2005.
The pace for drug trials in the country is so fast that the
Clinical Data Interchange Standards Consortium (CDISC),
USA, a non-profit organization committed to the development
of clinical research organizations' standards the world over, is
looking at setting up its chapter in India.
Global consultancy McKinsey & Co estimates that by 2010,
global pharmaceutical majors would spend around $1-1.5
billion just for drug trials in the country. However business in
India seems to have been affected adversely owing to recent
happenings.
Unethical clinical trials in the country have raised issues since
the controversial drug trials of letrozole, streptokinase and
nordihydroguairetic acid. The Times (London) reported that as
many as 49 infants have died during clinical trials at the
government-owned All-India Institute of Medical Sciences
(AIIMS). But, ethics is also an important part of medical
research, till recently being neglected in India. According to a
survey conducted by the Indian Council of Medical Research
(ICMR), Ethics Committees (ECs) are functioning in over 200
institutions. However, there is no accreditation of these ECs.
Besides, some ECs have an irregular schedule of meetings,
lack standard operating procedures, and do not have a
composition in line with GCP guidelines. This led to severe
opposition and strong pressure on the government to take
action.
The Government has established a national registry to
scrutinize trials in order to ensure compliance with ethical
guidelines. The ICMR has also planned to review and audit
the functioning of ECs and to introduce a national
accreditation system for them. India can also implement some
of the steps taken by the Malaysian government feasible here
like introducing a web based integrating system and also
consider other features to promote trials in India. The other
aspects of regulatory revisions such as adoption of Good
Clinical Practices (GCP) guidelines, removal of import duty on
clinical trial samples, elimination of restrictions on concurrent
trials, anticipated patent law changes have shown India's
seriousness about becoming a hub of global clinical trials.
Compiled by: Ashish Mishra, Queeny Bubna, MBA-BT (Sem II)
“Behind every successful woman
there is a MAN!”
Mrs. Rupali Tople, PUMBA MBA-BT (2004) alumna, has
played a key role in setting up of Criterium Inc., a US based
Contract Research Organisation. She was the first employee
of the company in India. The PUMBA Gazette interview team
caught up with one of our own woman achievers. A glimpse
of the conversation:
1. Can you brief us about your company?
Criterium Inc is a Full Service Contract Research Organization, with
its headquarters located in New York, USA. It was founded by our
President and Founder Mr. John Hudak way back in 1991 in New
Jersey, USA.
Our Business model is to connect our network of staff, contractors,
partners, Investigative sites, and Patients using technology. We not
only sell technology; we also sell efficient processes with a staff to
back them up.
We are a result driven Service Company that provides high Quality
project management services organized around patient enrolment
and real time data acquisition.
Our global reach enables 24/7 operations.
2. Why was Pune chosen as a location for setting up the branch?
Pune is a growing city, especially for clinical research, has good
talent, good network of hospitals, good connectivity to places across
the country.
Besides, Pune has been a dream place to work for many young
aspirants who have been working in different corners of our country.
It’s a ‘welcome back to their home’ town!
3. A gender bias is usually observed in India. Did you as a
woman face any difficulties while setting up the organization?
No, not at all!! Gender biasing for me is a history. In our organization
we have strong policies supported by a very good culture and work
environment.
4. Which countries do you consider as a potential hub for
clinical research?
Apart from India, countries like Singapore, China, Malaysia, are the
potential hub for Clinical research in the coming days.
5. The Malaysian government is promoting clinical research in
full swing in Malaysia. What according to you should the
Government of India do in order to promote clinical research in
India?
India is not far behind. As you can see, today we have all the top
CRO’s, and also a good number of pharmaceutical companies based
in India. This would not have happened without the government’s
support.
However, I do feel a strong requirement for learning and simplifying
certain processes like approval timelines, as compared to the other
nations.
But on the other hand, we have an added benefit of faster patient
recruitment.
Certain recent changes in regulatory affairs encourage clinical trials in
India. In 2005, schedule Y of the Drugs and cosmetics Act was
amended. Earlier foreign drugs trials could be conducted only at one
phase below the highest phase of testing abroad.
Now parallel global clinical trials are possible in India. Permission is
granted for concomitant phase II and Phase III trials.
6. India faces cost competition from China, Brazil, Russia and
Mexico. What is your take on it?
Due to globalization, world has become a smaller place, and today is
the time for “Survival of the fittest”.
I truly believe in Warren Buffet’s advice statement for 2009-
“Hard work-All hard work brings a profit, but mere talks lead only to
poverty.”
Hard work, dedication, determination, quality of work and wise
spending are the keys to success and beat the competition as well.
7. The U.S. administration has taken an unfavourable approach
towards outsourcing in the life science sector. U.S. is a big
source for the Indian clinical research market. What is your
opinion on this decision?
Decisions like these are taken at a national level in the best interest of
the citizens, hence I totally respect it. We are a country of potential
and intellectual citizens, who have proved their mettle in difficult times
in the past and we will continue to do so in future as well.
8. It has been observed that the Life Sciences sector has not
been hit hard by the recession. Please comment.
Although health care and pharmaceutical industries have been
traditionally viewed as recession proof, the present upheaval in global
financial markets has had and will continue to have a considerable
impact on this sector. The discovery and development of new drugs
remains an important resource & capital intensive enterprise, hence
challenging financial environment will force players to review their
priorities, rationalize ongoing initiatives, and explore alternative
models.
9. How does your company plan to deal with the recession?
We have strong employee retention policies and strategies developed
to take care of cost outs with no or minimal impact to our employees.
Positive aspect of recession is that it brings out the best in you and
your organization as well.
10. Do you consider entrepreneurship to be the need of the hour
in this recession period?
Yes, entrepreneurship is the need of the hour. Any small business
started with good foundation can reap good benefits in long run.
In today’s fast growing world one cannot depend on the single source
of income.
11. What is your secret of maintaining a balance between your
work and family?
Work and family play equal importance in one’s life. Maintaining the
right balance always helps.
I generally plan my work, and my day, be it official or personal. This
helps me prioritize my responsibilities and duties and I can cater to
each task effectively and in timely manner.
Also, I have a very strong support from my family and especially my
husband who equally understands me and respects my style of work.
In fact I would proudly love to say that ‘behind every successful
woman there is a MAN!’
Compiled by: The PUMBA Gazette Interview Team.
PUMBA NEWS

1) PUMBA in association with CSIR-IPR Chair, University of

Pune, had organized an International Conference on Global
th st
Meltdown - Opportunities and Challenges on 20 and 21
March, 2009 at PUMBA. The economic crisis faced by the world
economy today has forced both- the government and corporate
authorities that are responsible for governance to take a hard look
at the way they have been handling the issues faced by the world.
Thus the Conference proposed to focus on these issues in order
to reinvent the whole gamut of things, which would lead to a
paradigm shift and bring the economy back on track and ensure
sustainable business environment. Academic scholars, practicing
professionals and management students participated in the event
and shared their thoughts on the various themes through their
research papers. Close to 500 abstracts were received, out of
which around 250 were shortlisted for final presentations.

Dr. Narendra Jadhav (Hon’ble Vice Chancellor, University of

Pune) was the Chief Patron of the Conference and Dr. (Capt.)
C.M. Chitale (Prof. & Dean, PUMBA and CSIR-IPR Chair
Professor), Dr. Pandit Vidyasagar (Director-BCUD) and Dr. M. L.
Jadhav (Registrar) were the Patrons. Dr. B. V. Sangvikar (Prof. &
Head, PUMBA) was at the Conference Chair. The inaugural
function at the IUCCA Auditorium started with the lighting of the
lamp by Dr. Narendra Jadhav and the other dignitaries present.
Dr. Narendra Jadhav released the conference proceedings of the
selected papers which were compiled in the abstract book
followed by addresses made by the dignitaries who gave their
valuable inputs on the current economic situation in the world
economy.

The first day of the conference ended with a melodious ghazal

program. The paper presentations by the delegates and students
continued on the second day of the conference. The Valedictory
Session in the afternoon saw a number of eminent guests making
their presence felt. The Chief Guest for the session was Dr.
Ganesh Natrajan (Chairman NASSCOM, CMD, Zensar
Technologies), the guest of Honor, Dr. P.C. Shejwalkar
(Professor Emeritus), Dr. (Capt.) C. M. Chitale, Dean, Faculty of
Management, Dr. B.V. Sangvikar, Head of the Department and
Dr. Praful Pawar (Conference Secretary). The winners of the
Student Research Paper Contest were awarded prizes and 2) The BIOASIA 2009 organized by the Federation of Asian
certificates by the guests. Biotech Associations (FABA) from February 2-4 2009 at
Hyderabad International Convention Centre (HICC), was an
excellent platform for the students of first semester of MBA
Biotechnology to become aware of the current biotech scenario
both at the domestic and the global front. This Global Bio
Business Forum attracted both scientists and business leaders
from all over the world covering 18 countries. Discussions were
held on the current economic meltdown and its impact on the
sector. The panel discussions were mainly focused on:-

1. Innovative solutions to funding challenges.

2. Partnerships in drug discovery in Asian countries.
3. Business drivers leading to collaborations in licensing.
4. Oncology & Monoclonal Antibodies.
5. Vaccines- India’s Strength.
6. Service sectors.
7. Nanotechnology & CADD approaches for drug
discovery.
8. Stem cell research scenario in India.
9. Manpower challenges in Biotechnology.
There was also an exhibition of various
companies from all over the world all the three days. This
conference provided a direct interaction between students and
people from corporate world.